Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Growth Forecast Through 2030: Market Size And Trends In 2026
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Size And Revenue Outlook Through 2030
The artificial intelligence (AI)-powered chronic heart failure digital coach market size has seen substantial expansion in recent years. It is anticipated to grow from $1.93 billion in 2025 to $2.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 28.3%. The historical increase can be ascribed to elements such as the rising incidence of heart failure, increased adoption of remote patient monitoring, growing healthcare digitization, the expanding availability of connected medical devices, and an elevated focus on preventive cardiac care.
The artificial intelligence (AI)-powered chronic heart failure digital coach market is projected to experience substantial growth over the next few years. It is forecast to reach $6.64 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 28.0%. This expansion during the forecast period is largely attributable to advancements in AI-powered clinical analytics, the increasing adoption of personalized care management, the broadening scope of home-based cardiac monitoring, rising investments in digital cardiology platforms, and a growing demand for continuous patient engagement solutions. Key developments anticipated in the forecast period include the increasing deployment of AI-based cardiac monitoring coaches, greater integration with wearable heart sensors, a rise in the use of predictive health analytics, the expansion of remote chronic care platforms, and an enhanced focus on patient self-management tools.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing prevalence of cardiovascular diseases is anticipated to spur the expansion of the artificial intelligence (AI)-powered chronic heart failure digital coach market moving forward. Cardiovascular diseases encompass a variety of heart and blood vessel conditions, including coronary heart disease, cerebrovascular disease, and other ailments affecting the circulatory system. The incidence of these diseases is escalating as diets high in processed foods and salt contribute to elevated blood pressure and cholesterol, thus heightening the risk of heart disease. An AI-powered chronic heart failure digital coach assists in managing cardiovascular diseases by continuously monitoring health and providing tailored advice on medications and lifestyle, while also enabling early detection of complications and proactive care. For instance, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that 919,032 people in the United States died from cardiovascular disease in 2023, accounting for approximately one in every three deaths nationwide. Therefore, the increasing burden of cardiovascular diseases is stimulating the growth of the artificial intelligence (AI)-powered chronic heart failure digital coach market.
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Segment Landscape: Which Areas Lead Development?
The artificial intelligence (AI)-powered chronic heart failure digital coach market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Remote Patient Monitoring, Personalized Care Management, Medication Adherence, Patient Education, Other Applications
4) By End-User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Software: Cloud-Based Platforms, Mobile Applications, Data Analytics Tools, Patient Monitoring Dashboards, Integration Middleware
2) By Hardware: Wearable Devices, Smart Sensors, Connected Medical Devices, Home Monitoring Equipment, Edge Computing Devices
3) By Services: Implementation And Integration Services, Consulting Services, Maintenance And Support Services, Training And Education Services, Remote Patient Monitoring Services
#Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Growth Trends: What’s Shaping The Future Outlook?
Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are concentrating on creating at-home monitoring solutions, including non-invasive heart failure management platforms, aimed at enhancing medication compliance and facilitating proactive disease control. These non-invasive heart failure management platforms are digital tools designed to track heart function and patient vital signs without surgical procedures, employing sensors, wearables, and AI analytics to observe symptoms and inform therapy for timely intervention and better disease management. As an illustration, in September 2024, Astellas Pharma Inc., a pharmaceutical company based in Japan, introduced DIGITIVA, which is a new non-invasive digital health solution for managing heart failure, having secured its Food and Drug Administration (FDA) listing. This solution allows for at-home disease monitoring and is structured to be patient-centric, integrating the CORE 500 Digital Stethoscope, a smartphone application developed on Welldoc’s platform, educational materials from the American Heart Association, and a dedicated clinical review team, all aimed at facilitating early intervention and enhancing clinical outcomes, including a reduction in acute events and hospitalizations.
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Industry Leaders And Competitive Landscape
Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS.
View The Full Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report:
Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2025. The regions covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
